![Analysis of Mass Spec data (dashed-line) of fractions stained with Cytokeratin 18 Anti-Human MS-QAVA™ monoclonal antibody [Clone: DC10] (solid-line), reveals that less than 8.3% of signal is attributable to non-specific binding of anti-Cytokeratin 18 [Clone: DC10] to targets other than KRT18 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.](https://cdn-enquirebio.pressidium.com/wp-content/uploads/2017/10/enQuire-Bio-3875-MSM1-P1-anti-Cytokeratin-18-Anti-Human-antibody.png "Cytokeratin 18 Anti-Human Antibody Mass Spec Validation Data")
PDF DatasheetHuman Anti-Cytokeratin 18 Anti-Human Antibody Product Attributes
Cytokeratin 18 Anti-Human Previously Observed Antibody Staining Patterns
Observed Subcellular, Organelle Specific Staining Data:
Variations in Cytokeratin 18 antibody staining intensity in immunohistochemistry on tissue sections are present across different anatomical locations. An intense signal was observed in bile duct cells in the liver, cells in the tubules in kidney, exocrine glandular cells in the pancreas, glandular cells in the appendix, breast, cervix, uterine, colon, duodenum, endometrium, epididymis, fallopian tube, gallbladder, parathyroid gland, prostate, rectum, salivary gland, seminal vesicle, small intestine, stomach and thyroid gland, hepatocytes in liver, pneumocytes in lung, respiratory epithelial cells in the bronchus and nasopharynx and trophoblastic cells in the placenta. More moderate antibody staining intensity was present in bile duct cells in the liver, cells in the tubules in kidney, exocrine glandular cells in the pancreas, glandular cells in the appendix, breast, cervix, uterine, colon, duodenum, endometrium, epididymis, fallopian tube, gallbladder, parathyroid gland, prostate, rectum, salivary gland, seminal vesicle, small intestine, stomach and thyroid gland, hepatocytes in liver, pneumocytes in lung, respiratory epithelial cells in the bronchus and nasopharynx and trophoblastic cells in the placenta. Low, but measureable presence of Cytokeratin 18 could be seen in. We were unable to detect Cytokeratin 18 in other tissues. Disease states, inflammation, and other physiological changes can have a substantial impact on antibody staining patterns. These measurements were all taken in tissues deemed normal or from patients without known disease.
Observed Antibody Staining Data By Tissue Type:
Tissues from cancer patients, for instance, have their own distinct pattern of Cytokeratin 18 expression as measured by anti-Cytokeratin 18 antibody immunohistochemical staining. The average level of expression by tumor is summarized in the table below. The variability row represents patient to patient variability in IHC staining.
| Sample Type | breast cancer | carcinoid | cervical cancer | colorectal cancer | endometrial cancer | glioma | head and neck cancer | liver cancer | lung cancer | lymphoma | melanoma | ovarian cancer | pancreatic cancer | prostate cancer | renal cancer | skin cancer | stomach cancer | testicular cancer | thyroid cancer | urothelial cancer |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Signal Intensity | ++ | +++ | ++ | +++ | +++ | – | – | +++ | +++ | – | – | +++ | +++ | +++ | ++ | – | +++ | – | +++ | ++ |
| KRT18 Variability | ++ | + | +++ | ++ | + | + | ++ | ++ | ++ | + | + | + | + | + | ++ | + | + | ++ | + | ++ |
| Cytokeratin 18 Anti-Human General Information | |
|---|---|
| Alternate Names | |
| Cell Proliferation-inducing Gene 46 Protein, CK18, CYK18 Cytokeratin Endo B, K18, Keratin-18, Kerd, KRT18, anti-Cell Proliferation-inducing Gene 46 Protein antibody, anti-CK18 antibody, anti-CYK18 Cytokeratin Endo B antibody, anti-K18 antibody, anti-Keratin-18 antibody, anti-Kerd antibody, and anti-KRT18 antibody | |
| Molecular Weight | |
| 45kDa | |
| Chromosomal Location | |
| 12q13.13 | |
| Curated Database and Bioinformatic Data | |
| Gene Symbol | KRT18 |
| Entrez Gene ID | 3875 |
| Ensemble Gene ID | ENSG00000111057 |
| RefSeq Protein Accession(s) | NP_954657, NP_000215 |
| RefSeq mRNA Accession(s) | NM_199187, NM_000224 |
| RefSeq Genomic Accession(s) | NC_000012, NG_008351, NG_008402, NC_018923 |
| UniProt ID(s) | P05783, A0A024RAY2 |
| UniGene ID(s) | P05783, A0A024RAY2 |
| HGNC ID(s) | 6430 |
| Cosmic ID(s) | KRT18 |
| KEGG Gene ID(s) | hsa:3875 |
| PharmGKB ID(s) | PA30217 |
| General Description of Cytokeratin 18 Anti-Human. | |
| This MAb reacts with a wide variety of simple epithelia. It does not react with stratified squamous epithelia. It reacts with epithelial tumors of the gastrointestinal tract, lung, breast, pancreas, ovary, and thyroid. Cytokeratin 18, which belongs to the type A (acidic) subfamily of low molecular weight keratins, exists in combination with cytokeratin 8. It is reported that tissues from gastrointestinal tract are positive for both cytokeratin 8 and 18 but do not contain cytokeratin 14. Tissues from gastrointestinal tract, respiratory tract and urogenital tract, as well as endocrine and exocrine tissues and mesothelial cells are positive for cytokeratin 18. | |
There are no reviews yet.